Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Candesartan 8mg among final 16 price concessions announced for April

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 16 items for April 2019 prescriptions.

An initial 30 prices for the month were announced on April 16, followed by a further 25 prices on April 18.

Drug
Strength
Form
Price
Bumetanide
1mg
tablets (28)
£1.39
Candesartan
8mg
tablets (28)
£2.30
Co-careldopa
25mg/100mg
tablets (100)
£10.00
Finasteride
5mg
tablets (28)
£1.34
Irbesartan
75mg
tablets (28)
£2.18
Irbesartan
150mg
tablets (28)
£3.16
Nebivolol
5mg
tablets (28)
£5.29
Pantoprazole
20mg
tablets (28)
£1.73
Pantoprazole
40mg
tablets (28)
£3.65
Quetiapine
200mg
tablets (60)
£12.78
Quetiapine
300mg
tablets (60)
£9.99
Riluzole
50mg
tablets (56)
£115.68
Risedronate sodium
35mg
tablets (4)
£7.27
Telmisartan
80mg
tablets (28)
£6.62
Tolbutamide
500mg
tablets (28)
£22.70
Topiramate
50mg
tablets (60)
£12.27

Earlier this month (April 9), the Pharmaceutical Services Negotiating Committee told C+D it is becoming “increasingly concerned” about the impact of generics supply issues, after a record 96 price concessions were agreed for March.

Do these prices reflect the ones you have paid in April?

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD005871

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel